Search Within

Nadeem Abu-Rustum

  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (169)
  2. Meeting Abstract (114)
  3. Review (4)
  4. Correspondence (1)
Groups
  1. GDMT, Surgery (288)
  2. Gynecologic Medicine Service (288)
  3. Gynecology Disease Management Team (288)
  4. Solid Tumor Oncology Division (288)
  5. Surgery (288)
  6. Department of Medicine (287)

More Groups

People
  1. Carol Aghajanian (123)
  2. Mario Leitao (112)
  3. Dennis Chi (109)
  4. Britta Weigelt (102)
  5. Kaled Alektiar (90)
  6. Yukio Sonoda (90)

More People

Years
  1. 2025 (9)
  2. 2024 (29)
  3. 2023 (30)
  4. 2022 (32)
  5. 2021 (20)
  6. 2020 (24)

More Years

Publications
  1. Gynecologic Oncology (151)
  2. International Journal of Gynecological Cancer (49)
  3. Journal of Clinical Oncology (18)
  4. Modern Pathology (12)
  5. Laboratory Investigation (8)
  6. Cancer (5)

More Publications

Publishers
  1. Elsevier Inc. (159)
  2. Lippincott Williams & Wilkins (50)
  3. American Society of Clinical Oncology (24)
  4. Nature Research (12)
  5. Nature Publishing Group (11)
  6. American Association for Cancer Research (8)

More Publishers

Results (288)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular characterization of stage I, grade 3 endometrioid endometrial cancer
    Meeting Abstract

    Zammarrelli, B.; Paula, A. D.; Manning-Geist, B.; Kim, S.; Leitao, M.; Abu-Rustum, N.; Makker, V.; Ellenson, L.; Mueller, J.; Weigelt, B.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Meeting Abstract

    Zammarrelli, B.; Nandakumar, S.; Kertowidjojo, E.; Nguygen, B.; Paula, A. D.; Rios-Doria, E.; Smith, S.; Momeni-Boroujeni, A.; Aghajanian, C.; Mueller, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Oncologic outcomes of sentinel lymph node mapping versus lymph node dissection in staging of apparent uterine-confined clear cell carcinoma
    Meeting Abstract

    Dagher, C.; Sassine, D.; Abu-Rustum, N. R.; Mueller, J. J.; Borach, V.; Zivanovic, O.; Sonoda, Y.; Friedman, C.; Leitao, M. M.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer
    Journal Article

    Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer
    Journal Article

    Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Modern associations of uterine carcinomas with prior exposure to tamoxifen
    Meeting Abstract

    Rios-Doria, E.; Hodgson, A.; Aviki, E.; Zivanovic, O.; Friedman, C.; Aghajanian, C.; Makker, V.; Liu, Y.; Zamarin, D.; Leitao, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Germline drivers of gynecologic carcinosarcoma
    Meeting Abstract

    Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes
    Meeting Abstract

    Praiss, A.; Park, K.; Zhou, Q.; White, C.; Iasonos, A.; Zivanovic, O.; Abu-Rustum, N.; Weigelt, B.; Aghajanian, C.; Grisham, R.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer
    Meeting Abstract

    Praiss, A.; Moukarzel, L.; Zhu, Y.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Hanlon, E.; Gardner, G.; Roche, K. L.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • My individualized risk reduction for ovarian cancer (MIRROR): Development of a patient decision aid for risk-reducing surgery in hereditary risk for ovarian cancer
    Meeting Abstract

    Feinberg, J.; Gordhandas, S.; Austria, M.; Carlsson, S.; Abu-Rustum, N.; Liu, Y.; Roche, K. L.
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save